Skip to main content
Verified Statutory Healthcare Resource — Indian Pharmacopoeia (IP) / CDSCO / PMBJP Jan Aushadhi Standards
Diabetes & Metabolism 5 min read • Last Updated: September 2026

Normal Fasting vs Post-Prandial (PP) Blood Glucose Levels in Indian Adults

Detailed clinical chart for Fasting Blood Sugar (FBS) and 2-Hour Post-Prandial (PPBS): testing protocols, normal ranges, impaired glucose tolerance,...

Statutory Medical Disclaimer & Emergency Safety Notice The pharmacological and therapeutic data presented in this educational guide is synthesized exclusively for public health literacy, academic reference, and educational purposes in conformity with the Indian Pharmacopoeia (IP 2022) and guidelines established by the Central Drugs Standard Control Organisation (CDSCO). This content does not constitute medical diagnosis, formal physician opinion, or individualized therapeutic instruction. Under the Drugs and Cosmetics Act, 1940 and the National Medical Commission (Professional Conduct) Regulations, Schedule H, H1, and X pharmaceutical formulations must be prescribed and monitored by a registered medical practitioner (RMP). Patients must not initiate, alter, or terminate any therapeutic drug regimen without formal clinical evaluation by their treating physician or a licensed healthcare professional. For acute medical emergencies, dial 112 / 108 (India) immediately.
🩺 Quick Clinical Answer

In non-diabetic adults, normal Fasting Blood Sugar (measured after an 8-10 hour overnight fast) is between 70 and 99 mg/dL. Normal 2-Hour Post-Prandial Blood Sugar (measured exactly 2 hours after the start of a meal) is below 140 mg/dL. For treated diabetics, the American Diabetes Association targets are 80-130 mg/dL fasting and under 180 mg/dL post-prandial.

1. Diagnostic Fasting & PP Thresholds

Fasting: Normal = 70-99 mg/dL; Impaired Fasting Glucose (Pre-diabetes) = 100-125 mg/dL; Diabetes = 126+ mg/dL. Post-Prandial (2 hrs): Normal = <140 mg/dL; Impaired Glucose Tolerance = 140-199 mg/dL; Diabetes = 200+ mg/dL.

2. The Exact 2-Hour Timing Rule for PPBS

Start your 2-hour timer from the MOMENT YOU TAKE YOUR FIRST BITE of food, not from when you finish eating. Testing 2 hours from your first bite captures true post-prandial insulin response.

3. Glucometer Strip Storage Precautions

Test strips degrade rapidly in hot, humid Indian weather. Keep test strip vials tightly capped immediately after removing a strip, and never store in the bathroom or near windows.

PMBJP Jan Aushadhi Price Transparency

Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison

Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.

Brand Name Leading Manufacturer Active Salt Formulation (IP) Branded MRP Jan Aushadhi Price Savings %
Augmentin 625 Duo GlaxoSmithKline Pharmaceuticals Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP ₹220.00 ₹58.00 74%
Dolo 650 Micro Labs Ltd Paracetamol (Acetaminophen) 650mg IP ₹34.00 ₹5.50 84%
Pantocid 40 Sun Pharmaceutical Industries Pantoprazole Sodium 40mg IP (Gastro-resistant) ₹155.00 ₹8.00 95%
Azithral 500 Alembic Pharmaceuticals Azithromycin Dihydrate 500mg IP ₹132.00 ₹24.00 82%
Glycomet 500 USV Private Limited Metformin Hydrochloride 500mg IP ₹24.00 ₹4.50 81%
Shelcal 500 Torrent Pharmaceuticals Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP ₹134.00 ₹16.00 88%
Telma 40 Glenmark Pharmaceuticals Telmisartan 40mg IP ₹92.00 ₹7.50 92%
Montair-LC Cipla Ltd Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP ₹210.00 ₹18.00 91%
Combined 8-Drug Essential Therapy Basket Total: ₹1,001.00 ₹141.00 85.9% Net Savings
Additional high-volume Indian medicines bioequivalent generic savings: Atorva 10 (Atorvastatin 10mg: Branded ₹110.00 vs Jan Aushadhi ₹12.00, 89% savings), Allegra 120 (Fexofenadine 120mg: Branded ₹215.00 vs Jan Aushadhi ₹32.00, 85% savings). Official Portal: PMBJP National Formulary (janaushadhi.gov.in) →

Frequently Asked Questions (Clinical & Regulatory)

Q1: Can I drink black tea or water before a fasting blood test?

Plain water is completely fine and encouraged to prevent dehydration. Do not drink tea, coffee, milk, or chew gum as they trigger metabolic enzymes.

Q2: Why is fasting sugar sometimes higher than night bedtime sugar (Dawn Phenomenon)?

The liver naturally releases a burst of stored glucose between 4 AM and 8 AM stimulated by morning cortisol and growth hormone, known as the Dawn Phenomenon.

Q3: What makes Metformin Hydrochloride IP the universal first-line therapy in Type 2 Diabetes?

Metformin Hydrochloride (e.g. Glycomet 500) acts primarily by activating AMP-activated protein kinase (AMPK) in hepatocytes, suppressing hepatic gluconeogenesis and enhancing peripheral insulin sensitivity without stimulating pancreatic beta cells or causing weight gain.

Q4: How do PMBJP generic diabetes medicines compare with branded formulations?

Generic Metformin, Glimepiride, and Voglibose formulations at Jan Aushadhi Kendras undergo NABL testing and provide equivalent glycemic control at 80% to 90% cost savings for chronic life-long daily management.

Q5: What is the clinical Rule of 15 for managing acute hypoglycemia?

When blood glucose falls below 70 mg/dL with adrenergic symptoms, consume 15 grams of fast-acting carbohydrate (e.g., 3 glucose tablets, 1/2 cup fruit juice, or 3 teaspoons sugar), wait 15 minutes, and re-check capillary blood glucose. Repeat if readings remain below 70 mg/dL.

MediMatch AI Clinical Pharmacology Review Board
Clinically reviewed by Dr. Vikram Anand, MBBS, MD (Clinical Pharmacology), Dr. Aditi Sharma, MD Pharmacology & Dr. Rajesh Nair, PharmD, RPh

This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.

Official Statutory References: Indian Pharmacopoeia Commission (ipc.gov.in) → PMBJP Jan Aushadhi Portal (janaushadhi.gov.in) → CDSCO Health & Family Welfare (cdsco.gov.in) →
Digital Personal Data Protection (DPDP) Act, 2023 Statutory Health Privacy Disclosure

Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.